HBI 2022

 

HBI 2022: Panel sees a rosy future for ophthalmology

Ophthalmology continues to be a big area of investor interest, with considerable scope for consolidation in both healthcare services and also medical devices. As governments in the UK, Finland and parts of Eastern Europe in particular continue to increase outsourcing, the potential to unlock additional private pay services is increasing, and upselling of more complex lenses is on the rise. An expert panel convened at HBI 2022 to discuss the opportunities and challenges in the post-pandemic landscape.
July 1, 2022

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.
July 1, 2022

HBI 2022: Dementia care clearly insufficient

The inexorable rise in the need for dementia care dominated the elderly care panel discussion at HBI 2022, whilst the global staffing crisis was also, inevitably, on the agenda. Is enough being done to prepare for the sharp rise in dementia patients expected in the coming years, and how are groups dealing with the war for talent? 
July 1, 2022

HBI 2022: M&A may slow in H2, but demand remains strong

“We are about to face a global recession,” conceded Hedley Goldberg, managing director at financial advisory group Rothschild, to a packed out audience at the plenary session on the M&A landscape at HBI 2022. “But it will be an unusual one with high levels of inflation and employment.”
July 1, 2022

HBI 2022: Trade associations preferred way for sector to defend itself

There were some eye catching audience poll results at the start of the Regulatory and Political Risk session at HBI 2022. A significant majority thought recent negative media coverage of for-profit health and care providers had impacted investor confidence - and that it would lead to new regulations.
June 30, 2022

HBI 2022: Is healthcare financially sustainable?

Daniela Hommel, CFO at healthcare communications firm Helios Global Health, starkly laid out the problem facing the healthcare sector at HBI 2022: “Healthcare is not financially sustainable if it continues along current trends. By 2050, 25% of GDP will have to go towards healthcare if these trends continue. This is not financeable."
June 30, 2022

HBI 2022: Lack of debt may hit M&A in second half

M&A deals in health care services such as the bid for British health and beauty retailer and pharmacy chain Boots are coming under threat as market uncertainty, interest rates and inflation soar. Massive deals may fail if debt dries up. This could lead to a further slow-down in M&A activity in the second half of 2022, following a record year 2021.
June 24, 2022
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us